Made Krisna Adi Jaya1,2, Fita Rahmawati1, Nanang Munif Yasin1, Zullies Ikawati1
1Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta,; 2Department of Pharmacy, Faculty of Math and Science, Universitas Udayana, Bali, Indonesia.For correspondence:- Zullies Ikawati Email: zullies_ikawati@ugm.ac.id Tel:+628156854012
Received: 19 October 2024 Accepted: 16 January 2025 Published: 28 January 2025
Citation: Jaya MK, Rahmawati F, Yasin NM, Ikawati Z. A case-control study on factors associated with hypoglycemia unawareness among the ambulatory type 2 diabetes mellitus patients in Bali, Indonesia. Trop J Pharm Res 2025; 24(1):109-116 doi: 10.4314/tjpr.v24i1.15
© 2025 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Purpose: To determine the factors related to hypoglycemia unawareness (HU) in patients with type 2 diabetes mellitus (T2DM) in Bali-Indonesia. Methods: A case-control study was conducted across three hospitals to investigate the incidence of HU as a primary outcome. Medical record data were collected to obtain information for further analysis. The primary data were analyzed using chi-square analysis, and variables with p-value ≤ 0.10 were further evaluated using multivariate logistic regression, with odds ratio (OR) parameters at 95 % confidence interval (CI). A two-tailed statistical analysis was then conducted, and p < 0.05 was considered statistically significant. Results: Results of the multivariate analysis showed that five variables were significantly associated with HU incidents. These included insulin users (OR: 6.15 (CI 95: 1.65 - 22.86)), chronic kidney diseases (CKD) (OR: 6.56 (CI 95: 1.41 - 30.39)), diabetic neuropathy (OR: 24.61 (CI 95: 5.17 - 117.11)), hypertension (OR: 3.76 (CI 95: 1.01 - 13.96)), and dyslipidemia (OR: 6.44 (CI 95: 1.62 - 25.71)). Conclusion: Variables in this study are in line with the characteristics of the ambulatory T2DM population in Bali-Indonesia. These factors are used as evidence by health workers in managing and mitigating the risk of HU, thereby reducing the associated health burden.